Donate Help Contact The AHA Sign In Home
American Heart Association
Stroke
Search: search_blue_button Advanced Search
Stroke. 1997;28:1648-1649

This Article
Right arrow Full Text
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Fong, G.C.Y.
Right arrow Articles by Heo, J. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Fong, G.C.Y.
Right arrow Articles by Heo, J. H.

(Stroke. 1997;28:1648-1649.)
© 1997 American Heart Association, Inc.


Articles

Caution With Praziquantel in Neurocysticercosis

G.C.Y. Fong, MRCP R.T.F. Cheung, MRCP, PhD

Division of Neurology, Department of Medicine, Queen Mary Hospital, Pokfulam Road, Hong Kong


*    Introduction
 
To the Editor:

We read with interest the case report, "Large Cerebral Infarction During Praziquantel Therapy in Neurocysticercosis," by Bang et al1 and would like to make the following comments.

From the first set of cerebrospinal fluid (CSF) findings, there was marked eosinophilia (41%), suggesting a heavy load of neurocysticercosis within the central nervous system. Together with the communicating hydrocephalus, there was strong evidence of significant inflammatory reactions at the skull base. Therefore, steroid therapy might have been advisable to prevent exacerbation of the inflammatory reactions due to the cysticidal effect of praziquantel.2 Cerebral angiitis and meningeal adhesion should have been anticipated. This is analogous to the treatment of tuberculous meningitis.3 In fact, steroid-dependent neurocysticercosis has been suggested as an inflammatory mechanism for neurological disturbances following praziquantel treatment.4

Second, praziquantel is known to cause seizures. Recently, we saw a 27-year-old Chinese woman who presented with subcutaneous nodules for several years. Skin biopsy confirmed cysticercosis. Although the skin nodules resolved after a course of praziquantel, she had two attacks of temporal lobe epilepsy with secondary generalization 1 month after treatment. She was rendered seizure free with sodium valporate. MRI of the brain revealed multiple small, ring-like lesions typical of neurocysticercosis.

A 30-year-old Nepalese woman presented with generalized tonic-clonic seizure. CT of the head revealed a small, solitary, ring-like enhancing lesion at the gray-white matter junction of the right high parietal lobe, with marked perifocal edema. She was seizure free while on sodium valporate. Praziquantel was started empirically by a neurosurgeon. One . . . [Full Text of this Article]

Ji Hoe Heo, MD, PhD

Department of Neurology, Yonsei University College of Medicine, Seoul, Korea




This article has been cited by other articles:


Home page
J. Clin. Microbiol.Home page
M. Marangi, B. Zechini, A. Fileti, G. Quaranta, and A. Aceti
Hymenolepis diminuta Infection in a Child Living in the Urban Area of Rome, Italy
J. Clin. Microbiol., August 1, 2003; 41(8): 3994 - 3995.
[Abstract] [Full Text] [PDF]